Velasco N, Catto G R, Edward N, Engeset J, Moffat M A
J Infect. 1984 Jul;9(1):69-78. doi: 10.1016/s0163-4453(84)94576-6.
In a retrospective survey of 92 cadaver renal transplant recipients, cytomegalovirus (CMV) infections were detected in 23 of 34 (68 per cent) patients treated with high doses of steroids but in only 27 of 58 (47 per cent) patients given low doses. Pretransplant blood transfusions were associated with both an improvement in one-year allograft survival-rates (P less than 0.05) and an increase in the incidence of CMV infections. When standardised for any transfusion effect, the incidence of CMV infections was significantly higher in those patients given high doses of steroids (P less than 0.05). In the same group of patients, moreover, CMV infections were associated with a statistically significant increase in the renal allograft survival-rate (P = 0.03).
在一项对92例尸体肾移植受者的回顾性调查中，34例接受大剂量类固醇治疗的患者中有23例（68%）检测到巨细胞病毒（CMV）感染，而在58例接受小剂量类固醇治疗的患者中只有27例（47%）检测到感染。移植前输血既与一年期移植肾存活率的提高有关（P<0.05），也与CMV感染发生率的增加有关。在对任何输血效应进行标准化后，接受大剂量类固醇治疗的患者中CMV感染的发生率显著更高（P<0.05）。此外，在同一组患者中，CMV感染与移植肾存活率的统计学显著提高有关（P = 0.03）。
